India  

Emergency Use Authorization

Granted by the Food and Drug Administration in the US

Emergency Use Authorization    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

An Emergency Use Authorization (EUA) in the United States is an authorization granted to the Food and Drug Administration (FDA) under sections of the Federal Food, Drug, and Cosmetic Act as added to and amended by various Acts of Congress, including by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), as codified by 21 U.S.C. § 360bbb-3, to allow the use of a drug prior to approval. It does not constitute approval of the drug in the full statutory meaning of the term, but instead authorizes FDA to facilitate availability of an unapproved product, or an unapproved use of an approved product, during a declared state of emergency from one of several agencies or of a "material threat" by the Secretary of Homeland Security.

0
shares
ShareTweetSavePostSend
 

J&J'S vaccine pause should be lifted -CDC advisers [Video]

J&J'S vaccine pause should be lifted -CDC advisers

Use of Johnson & Johnson's COVID-19 vaccine should be resumed in the United States, advisers to U.S. health regulators said on Friday, after weighing evidence of the shot's link to extremely rare but..

Credit: Reuters - Politics     Duration: 01:50Published

You Might Like


Biophore seeks EUA from DCGI for Aviptadil inhalation for Covid-19 treatment


IndiaTimes - Published

Ocugen to seek full approval for Covaxin in US via BLA instead of EUA

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
IndiaTimes - Published

Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
IndiaTimes - Published

Bio E's Corbevax may be India’s cheapest vaccine at Rs 250 per dose

Biological E’s recombinant protein Covid-19 vaccine, Corbevax, could well emerge as the most affordable of vaccines in the Indian market once it gets emergency use approval (EUA). Corbevax is slated..
IndiaTimes - Published

Natco gets EUA for Baricitinib use for Covid-19 treatment


IndiaTimes - Published

Dr Reddy's gets EUA for Sputnik V


IndiaTimes - Published

Covid-19: India approves Russian vaccine Sputnik V for emergency use

India on Monday granted Emergency Use Authorisation (EUA) to Russia's anti-covid vaccine Sputnik V, as the country fights the second wave of coronavirus. The EUA approval comes on the day India..
IndiaTimes - Published

Dr Reddy's initiates EUA process for Russian Covid-19 vaccine Sputnik V


IndiaTimes - Published

Pfizer wants India to order Covid-19 vaccine before pursuing approval

Pfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten. Pfizer..
IndiaTimes - Published

Covaxin led to tolerable safety outcomes & enhanced immune responses, says Lancet

Even as a controversy rages over the safety of India’s first indigenous Covid-19 vaccine Covaxin after it was granted Emergency Use Authorisation (EUA) even as Phase III efficacy trials are underway,..
IndiaTimes - Published

All-India vaccine rollout set for next week: Govt

The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
IndiaTimes - Published

Vaccine war: Bharat Biotech chief lashes out at Serum

Bharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was given to Covaxin, the company’s Covid-19..
IndiaTimes - Published

Happy New Year: Expert panel clears Oxford vaccine for India

India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum..
IndiaTimes - Published

Covid-19: Vaccine makers asked to submit more data

The drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and..
IndiaTimes - Published